Research

Spermidine

A dietary polyamine linked to autophagy in laboratory models, with early human trials that have not established cognitive, anti-aging, or longevity benefits.

Experimental
Evidence rating
Evidence review

What the evidence says

Spermidine is a polyamine present in food and produced within the body. It can promote autophagy in experimental systems, and animal or observational findings made it a proposed caloric-restriction mimetic, but these mechanisms do not establish a useful anti-aging dose in humans.[1]

A three-month randomized pilot in 30 older adults with subjective cognitive decline reported a moderate memory signal from a wheat-germ extract. The follow-up SmartAge trial randomized 100 adults for 12 months and found no significant improvement in its primary memory outcome or secondary biomarkers versus placebo.[2][3]

Oral pharmacology is also unresolved. A 12-person crossover study using 15 mg daily for five days did not raise plasma spermidine, while a company-funded 28-day trial of purified 40 mg daily in 37 older men found minimal circulating changes. A supplement dose therefore cannot be assumed to create the cellular exposure seen in laboratory experiments.[4][5]

A 2026 pilot in 40 older adults found improved immune and vaccine-response markers in selected vaccine nonresponders after 13 weeks, but this is a small exploratory result rather than proof of fewer infections, slower immune aging, or longer life. No randomized human study has demonstrated lifespan extension or a validated reduction in biological age.[6][1]

Short trials reported balanced adverse events or good tolerability, but they are too small and brief to define uncommon toxicity, cancer-related concerns, interactions, or safety in pregnancy and chronic disease. Food-derived extracts and purified spermidine salts also should not be treated as identical interventions.[3][5]

Potential benefits

  • Provides a plausible and testable human autophagy research target.[1][4]
  • Small pilot studies suggest possible immune or memory signals that warrant larger confirmatory trials.[2][6]

Side effects and cautions

  • Short trials have not identified a consistent common adverse-effect pattern, but their power and duration are limited.[3][5]
  • Long-term safety, medicine interactions, pregnancy safety, and risks in chronic disease remain inadequately characterized.[1][5]
How we scored it

Evidence breakdown

A promising pilot memory signal failed on the primary outcome in a larger 12-month trial; pharmacokinetics, effective dose, long-term safety, and clinical relevance remain unsettled.

Clinical relevanceLow

Human studies mainly assess cognition tests, polyamine levels, or exploratory immune biomarkers rather than healthy lifespan.

Study qualityLow

Trials are small and early phase, and the best longer cognitive trial was negative.

Safety dataLow

Short exposures appear tolerated, but purified high-dose and long-term population data are sparse.

References

Full source list

  1. Spermidine in health and disease

    Science · 2018

  2. The effect of spermidine on memory performance in older adults at risk for dementia: a randomized controlled trial

    Cortex · 2018

  3. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline

    JAMA Network Open · 2022

  4. High-Dose Spermidine Supplementation Does Not Increase Spermidine Levels in Blood Plasma and Saliva

    Nutrients · 2023

  5. Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines

    Nutrition Research · 2024

  6. Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults

    Aging Cell · 2026